• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

载脂蛋白(a) 第IV型kringle结构域6至10外显子中的单核苷酸多态性影响血浆中脂蛋白(a) 的浓度,并且在非洲人和高加索人中具有不同模式。

Single nucleotide polymorphisms in exons of the apo(a) kringles IV types 6 to 10 domain affect Lp(a) plasma concentrations and have different patterns in Africans and Caucasians.

作者信息

Ogorelkova M, Kraft H G, Ehnholm C, Utermann G

机构信息

Institute of Medical Biology and Human Genetics, University of Innsbruck, Schoepfstrasse 41, 6020 Innsbruck, Austria.

出版信息

Hum Mol Genet. 2001 Apr 1;10(8):815-24. doi: 10.1093/hmg/10.8.815.

DOI:10.1093/hmg/10.8.815
PMID:11285247
Abstract

Lipoprotein(a) [Lp(a)] is a complex of apolipoprotein(a) [apo(a)] and low-density lipoprotein which is associated with atherothrombotic disease. Lp(a) plasma levels are controlled to a large extent by the apo(a) gene locus. Known polymorphisms in the apo(a) gene, including the kringle (K) IV-2 variable number of tandem repeats, explain only part of the large interindividual variability and do not explain the differences in Lp(a) concentrations between major human ethnic groups. Here we performed screening for single nucleotide polymorphisms (SNPs) in exons and flanking intron sequences of the apo(a) K IV types 6, 8, 9 and 10 which represent 1.3 kb of coding sequence in two African (Khoi San, Black South Africans) and one Caucasian (Tyroleans) populations and investigated whether they affect Lp(a) levels. Together, 768 alleles were analyzed. We identified 14 SNPs, including 11 non-synonymous SNPs (eight of which involved conserved residues), one splice site and two synonymous base changes. No sequence variants common to Africans and Caucasians were found. Several of the newly identified SNPs showed significant effects on Lp(a) plasma concentrations. The substitutions S37F in K IV-6 and G17R in K IV-8 were associated with Lp(a) levels significantly below average in Africans. In contrast, the R18W substitution in K IV-9, which occurred with a frequency of 8% in Khoi San, resulted in a significantly increased Lp(a) concentration. Together, our data suggest that several SNPs in the coding sequence of apo(a) affect Lp(a) levels. This indicates that many SNPs may have subtle effects on the gene product.

摘要

脂蛋白(a)[Lp(a)]是载脂蛋白(a)[apo(a)]与低密度脂蛋白的复合物,与动脉粥样硬化血栓形成性疾病相关。Lp(a)血浆水平在很大程度上由apo(a)基因位点控制。apo(a)基因中已知的多态性,包括kringle(K)IV-2串联重复序列可变数目,仅解释了个体间巨大差异的一部分,并未解释主要人类种族之间Lp(a)浓度的差异。在此,我们对apo(a)K IV类型6、8、9和10的外显子及侧翼内含子序列中的单核苷酸多态性(SNP)进行了筛查,这些类型代表了两个非洲人群(科伊桑人、南非黑人)和一个高加索人群(蒂罗尔人)中1.3 kb的编码序列,并研究了它们是否影响Lp(a)水平。总共分析了768个等位基因。我们鉴定出14个SNP,包括11个非同义SNP(其中8个涉及保守残基)、1个剪接位点和2个同义碱基变化。未发现非洲人和高加索人共有的序列变异。几个新鉴定的SNP对Lp(a)血浆浓度有显著影响。K IV-6中的S37F替换和K IV-8中的G17R替换与非洲人Lp(a)水平显著低于平均水平相关。相反,K IV-9中的R18W替换在科伊桑人中出现频率为8%,导致Lp(a)浓度显著升高。总之,我们的数据表明apo(a)编码序列中的几个SNP影响Lp(a)水平。这表明许多SNP可能对基因产物有微妙影响。

相似文献

1
Single nucleotide polymorphisms in exons of the apo(a) kringles IV types 6 to 10 domain affect Lp(a) plasma concentrations and have different patterns in Africans and Caucasians.载脂蛋白(a) 第IV型kringle结构域6至10外显子中的单核苷酸多态性影响血浆中脂蛋白(a) 的浓度,并且在非洲人和高加索人中具有不同模式。
Hum Mol Genet. 2001 Apr 1;10(8):815-24. doi: 10.1093/hmg/10.8.815.
2
Frequency distributions of apolipoprotein(a) kringle IV repeat alleles and their effects on lipoprotein(a) levels in Caucasian, Asian, and African populations: the distribution of null alleles is non-random.载脂蛋白(a) kringle IV重复等位基因的频率分布及其对高加索、亚洲和非洲人群中脂蛋白(a)水平的影响:无效等位基因的分布并非随机。
Eur J Hum Genet. 1996;4(2):74-87. doi: 10.1159/000472175.
3
Molecular basis of congenital lp(a) deficiency: a frequent apo(a) 'null' mutation in caucasians.
Hum Mol Genet. 1999 Oct;8(11):2087-96. doi: 10.1093/hmg/8.11.2087.
4
Sequence polymorphisms in the apo(a) gene associated with specific levels of Lp(a) in plasma.载脂蛋白(a)基因中的序列多态性与血浆中特定水平的脂蛋白(a)相关。
Hum Mol Genet. 1995 Feb;4(2):173-81. doi: 10.1093/hmg/4.2.173.
5
Significant impact of the +93 C/T polymorphism in the apolipoprotein(a) gene on Lp(a) concentrations in Africans but not in Caucasians: confounding effect of linkage disequilibrium.载脂蛋白(a)基因中+93 C/T多态性对非洲人而非高加索人的Lp(a)浓度有显著影响:连锁不平衡的混杂效应。
Hum Mol Genet. 1998 Feb;7(2):257-64. doi: 10.1093/hmg/7.2.257.
6
Genomic structure and organization of kringles type 3 to 10 of the apolipoprotein(a) gene in 6q26-27.位于6q26 - 27的载脂蛋白(a)基因kringle 3至10型的基因组结构与组织
Gene. 1997 Sep 1;196(1-2):1-8. doi: 10.1016/s0378-1119(97)00091-7.
7
The Apo(a) gene is the major determinant of variation in plasma Lp(a) levels in African Americans.载脂蛋白(a)基因是非洲裔美国人血浆脂蛋白(a)水平变异的主要决定因素。
Am J Hum Genet. 1997 Aug;61(2):402-17. doi: 10.1086/514851.
8
Genetic control of lipoprotein(a) concentrations is different in Africans and Caucasians.脂蛋白(a)浓度的基因控制在非洲人和高加索人中有所不同。
Eur J Hum Genet. 1999 Feb-Mar;7(2):169-78. doi: 10.1038/sj.ejhg.5200290.
9
Single nucleotide polymorphisms in the apo(a) kringle IV type 8 domain are not associated with atherothrombotic serum lipoprotein (a) concentration, in a Portuguese paediatric population.在葡萄牙儿科人群中,载脂蛋白(a) 第IV型8结构域的单核苷酸多态性与动脉粥样硬化血栓形成血清脂蛋白(a) 浓度无关。
Int J Lab Hematol. 2008 Jun;30(3):240-3. doi: 10.1111/j.1751-553X.2007.00932.x.
10
The apolipoprotein (a) gene: a transcribed hypervariable locus controlling plasma lipoprotein (a) concentration.载脂蛋白(a)基因:一个控制血浆脂蛋白(a)浓度的转录高变位点。
Hum Genet. 1992 Nov;90(3):220-30. doi: 10.1007/BF00220066.

引用本文的文献

1
Lipoprotein(a)-Lowering Drugs: A Mini Review.降低脂蛋白(a)的药物:一篇小型综述。
J Clin Med Res. 2025 Apr;17(4):181-186. doi: 10.14740/jocmr6196. Epub 2025 Apr 11.
2
Lipoprotein (a) in the context of atherosclerosis: pathological implications and therapeutic perspectives in myocardial infarction. A narrative review.动脉粥样硬化背景下的脂蛋白(a):对心肌梗死的病理影响及治疗前景。一篇综述。
Rom J Morphol Embryol. 2024 Oct-Dec;65(4):609-616. doi: 10.47162/RJME.65.4.07.
3
Oral Muvalaplin for Lowering of Lipoprotein(a): A Randomized Clinical Trial.
口服穆瓦拉普林降低脂蛋白(a):一项随机临床试验。
JAMA. 2025 Jan 21;333(3):222-231. doi: 10.1001/jama.2024.24017.
4
Therapeutic Potential of Lipoprotein(a) Inhibitors.脂蛋白(a)抑制剂的治疗潜力。
Drugs. 2024 Jun;84(6):637-643. doi: 10.1007/s40265-024-02046-z. Epub 2024 Jun 8.
5
Discovery of potent small-molecule inhibitors of lipoprotein(a) formation.发现强效的脂蛋白(a)形成的小分子抑制剂。
Nature. 2024 May;629(8013):945-950. doi: 10.1038/s41586-024-07387-z. Epub 2024 May 8.
6
Lipoprotein(a) beyond the kringle IV repeat polymorphism: The complexity of genetic variation in the LPA gene.载脂蛋白(a)除了kringle IV 重复多态性:LPA 基因遗传变异的复杂性。
Atherosclerosis. 2022 May;349:17-35. doi: 10.1016/j.atherosclerosis.2022.04.003.
7
The effect of LPA Thr3888Pro on lipoprotein(a) and coronary artery disease is modified by the LPA KIV-2 variant 4925G>A.载脂蛋白(a)LPA Thr3888Pro 对脂蛋白(a)和冠状动脉疾病的影响受 LPA KIV-2 变异体 4925G>A 的修饰。
Atherosclerosis. 2022 May;349:151-159. doi: 10.1016/j.atherosclerosis.2022.04.023. Epub 2022 Apr 26.
8
Diet and Lp(a): Does Dietary Change Modify Residual Cardiovascular Risk Conferred by Lp(a)?饮食与 Lp(a):饮食改变是否能改变 Lp(a)带来的残余心血管风险?
Nutrients. 2020 Jul 7;12(7):2024. doi: 10.3390/nu12072024.
9
Nonsynonymous SNPs in homologous to plasminogen deficiency mutants represent novel null apo(a) alleles.无义 SNP 与纤溶酶原缺陷突变体同源,代表了新的无功能 apo(a)等位基因。
J Lipid Res. 2020 Mar;61(3):432-444. doi: 10.1194/jlr.M094540. Epub 2019 Dec 5.
10
Genetic Factors Explain a Major Fraction of the 50% Lower Lipoprotein(a) Concentrations in Finns.遗传因素解释了芬兰人 50%更低脂蛋白(a)浓度的主要部分。
Arterioscler Thromb Vasc Biol. 2018 May;38(5):1230-1241. doi: 10.1161/ATVBAHA.118.310865. Epub 2018 Mar 22.